Literature DB >> 15750600

Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome.

Paola Scaffidi1, Tom Misteli.   

Abstract

Hutchinson-Gilford progeria syndrome (HGPS) is a childhood premature aging disease caused by a spontaneous point mutation in lamin A (encoded by LMNA), one of the major architectural elements of the mammalian cell nucleus. The HGPS mutation activates an aberrant cryptic splice site in LMNA pre-mRNA, leading to synthesis of a truncated lamin A protein and concomitant reduction in wild-type lamin A. Fibroblasts from individuals with HGPS have severe morphological abnormalities in nuclear envelope structure. Here we show that the cellular disease phenotype is reversible in cells from individuals with HGPS. Introduction of wild-type lamin A protein does not rescue the cellular disease symptoms. The mutant LMNA mRNA and lamin A protein can be efficiently eliminated by correction of the aberrant splicing event using a modified oligonucleotide targeted to the activated cryptic splice site. Upon splicing correction, HGPS fibroblasts assume normal nuclear morphology, the aberrant nuclear distribution and cellular levels of lamina-associated proteins are rescued, defects in heterochromatin-specific histone modifications are corrected and proper expression of several misregulated genes is reestablished. Our results establish proof of principle for the correction of the premature aging phenotype in individuals with HGPS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15750600      PMCID: PMC1351119          DOI: 10.1038/nm1204

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  22 in total

Review 1.  Morpholino antisense oligomers: the case for an RNase H-independent structural type.

Authors:  J Summerton
Journal:  Biochim Biophys Acta       Date:  1999-12-10

Review 2.  Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing.

Authors:  Peter Sazani; Ryszard Kole
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

3.  Morpholino and phosphorothioate antisense oligomers compared in cell-free and in-cell systems.

Authors:  J Summerton; D Stein; S B Huang; P Matthews; D Weller; M Partridge
Journal:  Antisense Nucleic Acid Drug Dev       Date:  1997-04

4.  Mitotic misregulation and human aging.

Authors:  D H Ly; D J Lockhart; R A Lerner; P G Schultz
Journal:  Science       Date:  2000-03-31       Impact factor: 47.728

Review 5.  The Hutchinson-Gilford progeria syndrome. Report of 4 cases and review of the literature.

Authors:  F L DeBusk
Journal:  J Pediatr       Date:  1972-04       Impact factor: 4.406

6.  Antisense morpholino oligonucleotide analog induces missplicing of C-myc mRNA.

Authors:  R V Giles; D G Spiller; R E Clark; D M Tidd
Journal:  Antisense Nucleic Acid Drug Dev       Date:  1999-04

7.  Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C.

Authors:  F Lin; H J Worman
Journal:  J Biol Chem       Date:  1993-08-05       Impact factor: 5.157

8.  Domain-specific interactions of human HP1-type chromodomain proteins and inner nuclear membrane protein LBR.

Authors:  Q Ye; I Callebaut; A Pezhman; J C Courvalin; H J Worman
Journal:  J Biol Chem       Date:  1997-06-06       Impact factor: 5.157

9.  Alternative splicing in disease and therapy.

Authors:  Mariano A Garcia-Blanco; Andrew P Baraniak; Erika L Lasda
Journal:  Nat Biotechnol       Date:  2004-05       Impact factor: 54.908

10.  Novel lamin A/C gene (LMNA) mutations in atypical progeroid syndromes.

Authors:  A B Csoka; H Cao; P J Sammak; D Constantinescu; G P Schatten; R A Hegele
Journal:  J Med Genet       Date:  2004-04       Impact factor: 6.318

View more
  238 in total

Review 1.  Progeria syndromes and ageing: what is the connection?

Authors:  Christopher R Burtner; Brian K Kennedy
Journal:  Nat Rev Mol Cell Biol       Date:  2010-08       Impact factor: 94.444

2.  The H3K27 demethylase UTX-1 regulates C. elegans lifespan in a germline-independent, insulin-dependent manner.

Authors:  Travis J Maures; Eric L Greer; Anna G Hauswirth; Anne Brunet
Journal:  Aging Cell       Date:  2011-09-16       Impact factor: 9.304

Review 3.  The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches.

Authors:  Elisabeth Daguenet; Gwendal Dujardin; Juan Valcárcel
Journal:  EMBO Rep       Date:  2015-11-13       Impact factor: 8.807

Review 4.  Skin Disease in Laminopathy-Associated Premature Aging.

Authors:  Tomás McKenna; Agustín Sola Carvajal; Maria Eriksson
Journal:  J Invest Dermatol       Date:  2015-07-29       Impact factor: 8.551

Review 5.  Causes and consequences of nuclear envelope alterations in tumour progression.

Authors:  Emily S Bell; Jan Lammerding
Journal:  Eur J Cell Biol       Date:  2016-06-25       Impact factor: 4.492

Review 6.  A-type lamin complexes and regenerative potential: a step towards understanding laminopathic diseases?

Authors:  Josef Gotzmann; Roland Foisner
Journal:  Histochem Cell Biol       Date:  2005-09-02       Impact factor: 4.304

Review 7.  Laminopathies: multiple disorders arising from defects in nuclear architecture.

Authors:  Veena K Parnaik; Kaliyaperumal Manju
Journal:  J Biosci       Date:  2006-09       Impact factor: 1.826

Review 8.  Alternative splicing and disease.

Authors:  Jamal Tazi; Nadia Bakkour; Stefan Stamm
Journal:  Biochim Biophys Acta       Date:  2008-10-17

9.  Single molecule analysis of lamin dynamics.

Authors:  Leonid A Serebryannyy; David A Ball; Tatiana S Karpova; Tom Misteli
Journal:  Methods       Date:  2018-08-24       Impact factor: 3.608

Review 10.  Metabolic Signaling to Chromatin.

Authors:  Shelley L Berger; Paolo Sassone-Corsi
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-11-01       Impact factor: 10.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.